Assessing the Anti-Obesity Potential of Lactococcus lactis subsp. lactis CAB701: Modulation of Adipocyte Differentiation and Lipid Metabolism in In Vitro and In Vivo Models
Probiotics and Antimicrobial Proteins · 2025
DOI: 10.1007/s12602-023-10198-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Probiotics and Antimicrobial Proteins, 2025. Verfasst von Huijin Jeong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Biotechnology, Gachon University, Seongnam, 13120, Republic of Korea. Hauptthemen laut MEDLINE: Adipocytes, Lactococcus lactis, Lipid Metabolism, Obesity. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Ministry of SMEs and Startups.
Abstract (Originalsprache)
In this study, the potential anti-obesity effects of Lactococcus lactis subsp. lactis CAB701, a probiotic strain isolated from cabbage, were investigated using in vitro and in vivo assays. L. lactis subsp. lactis CAB701 inhibited adipocyte differentiation of 3T3-L1 cells by 67%. In an in vivo model of high-fat diet-induced obese mice, treatment with L. lactis subsp. lactis CAB701 markedly reduced body weight and peri-epididymal fat mass, and significantly reduced serum total cholesterol, triglycerides, and low-density lipoprotein cholesterol levels. Molecular analysis revealed a significant modulation of key genes and proteins involved in lipid metabolism and adipogenesis. Specifically, fatty acid synthase and peroxisome proliferator-activated receptor gamma were significantly downregulated in peri-epididymal adipose tissue, alluding to the molecular mechanism underlying the anti-obesity effects exerted by L. lactis subsp. lactis CAB701. Furthermore, histological examination revealed a significant reduction in adipocyte size in the treated group, indicating effective adipose tissue remodeling. Our findings suggest that L. lactis subsp. lactis CAB701 mediates anti-obesity effects through the modulation of critical molecular markers and lipid profiles. L. lactis subsp. lactis CAB701 thus represents a promising candidate for combating obesity and related metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food Science and Biotechnology, Gachon University, Seongnam, 13120, Republic of Korea.
- BKbio Co., Ltd., Jeju, 63359, Republic of Korea.
- Department of Food Science and Biotechnology, Gachon University, Seongnam, 13120, Republic of Korea. ypark@gachon.ac.kr.
Förderung
- Ministry of SMEs and Startups
Zitieren
APA
Jeong, H., Hwang, U. S., Choi, H., & Park, Y. S. (2025). Assessing the Anti-Obesity Potential of Lactococcus lactis subsp. lactis CAB701: Modulation of Adipocyte Differentiation and Lipid Metabolism in In Vitro and In Vivo Models. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-023-10198-9
Vancouver
Jeong H, Hwang US, Choi H, Park YS. Assessing the Anti-Obesity Potential of Lactococcus lactis subsp. lactis CAB701: Modulation of Adipocyte Differentiation and Lipid Metabolism in In Vitro and In Vivo Models. Probiotics and Antimicrobial Proteins. 2025. doi:10.1007/s12602-023-10198-9
BibTeX
@article{Jeong2025,
author = {Jeong, Huijin and Hwang, Un-Sik and Choi, Hyukjoon and Park, Young-Seo},
title = {Assessing the Anti-Obesity Potential of Lactococcus lactis subsp. lactis CAB701: Modulation of Adipocyte Differentiation and Lipid Metabolism in In Vitro and In Vivo Models},
journal = {Probiotics and Antimicrobial Proteins},
year = {2025},
doi = {10.1007/s12602-023-10198-9}
}
EUVIMED